DI

DT Investments

North America, Texas, United States, Houston

Description

DT Investments

Investor Profile

DT Investments has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in South Korea.
  • Strong thematic focus on Biotechnology, Pharmaceutical, Product Research.

Stage Focus

  • Series B (100%)

Country Focus

  • South Korea (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Product Research
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does DT Investments frequently co-invest with?

JB Ventures
Asia, Kyonggi-do, South Korea, Dongan
Co-Investments: 1
Stonebridge Capital
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
UTC Investment Co.
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Woori Bank
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Sejong Venture Partners
North America, New Jersey, United States, Fort Lee
Co-Investments: 1
LSK Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1

What are some of recent deals done by DT Investments?

Autotelic Bio

Cheongju, Ch'ungch'ong-bukto, South Korea

Autotelic Bio is a bio technology company that researches and develops anti-cancer drugs.

BiotechnologyPharmaceuticalProduct Research
Series BMar 28, 2022
Amount Raised: $12,665,468